Plasma Level of MMP-10 May Be a Prognostic Marker in Early Stages of Breast Cancer

Background: Stromelysins are potential breast cancer biomarkers. The aim of the study was to evaluate if plasma levels of selected metalloproteinases (MMPs) (stromelysin-1 (MMP-3) and stromelysin-10 (MMP-10)) and cancer antigen 15-3 (CA 15-3) used separately and in combination demonstrated diagnosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Piskór, Barbara Maria, Przylipiak, Andrzej, Dąbrowska, Emilia, Sidorkiewicz, Iwona, Niczyporuk, Marek, Szmitkowski, Maciej, Ławicki, Sławomir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767367/
https://www.ncbi.nlm.nih.gov/pubmed/33371324
http://dx.doi.org/10.3390/jcm9124122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767367/
https://www.ncbi.nlm.nih.gov/pubmed/33371324
http://dx.doi.org/10.3390/jcm9124122

Ejemplares similares